Literature DB >> 25941461

Age-dependent Electroencephalographic Differences in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS) Model of Absence Epilepsy.

Mohammad Rafiqul Islam1, Jafri Malin Abdullah2.   

Abstract

Genetic Absence Epilepsy Rats from Strasbourg (GAERS) are a prognostic genetic model of absence epilepsy. This model displays the electro-clinical, behavioural, and pharmacological features of absence seizures. Although GAERS share typical characteristics, including spike-and-wave discharges (SWDs) in the electroencephalography (EEG), age-dependent studies with these animals have not yet been reported. The aim of the present study is to perform a systematic comparison contrasting the SWDs of young and older GAERS, in terms of the number, duration, frequency, and waveform morphology of the discharges, as well as the pre-SWD EEG characteristics, using identical measurement and analysis techniques. The number, cumulative total duration and mean duration of SWDs were significantly higher in young GAERS (4 to 6 months) compared to older GAERS (12 to 14 months). Furthermore, the SWD spectra and average SWD waveforms indicated that a single cycle of the SWD contains more energy in faster components, such as increased spikes and higher power, in the SWDs of the young GAERS. Additionally, older GAERS showed weak amplitude spikes in SWDs and higher power pre-SWDs. These clear morphological differences in the EEGs of young and older GAERS rats should be further examined in future studies that explore new dimensions of genetic absence epilepsy.

Entities:  

Keywords:  electroencephalography; epilepsy; frequency; rat; seizure

Year:  2014        PMID: 25941461      PMCID: PMC4405807     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  23 in total

Review 1.  Typical absence seizures and their treatment.

Authors:  C P Panayiotopoulos
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 2.  Typical absence seizures and related epileptic syndromes: assessment of current state and directions for future research.

Authors:  Chrysostomos P Panayiotopoulos
Journal:  Epilepsia       Date:  2008-12       Impact factor: 5.864

3.  Opposite effects of GABAB receptor antagonists on absences and convulsive seizures.

Authors:  M Vergnes; A Boehrer; S Simler; R Bernasconi; C Marescaux
Journal:  Eur J Pharmacol       Date:  1997-08-13       Impact factor: 4.432

4.  The morphology of the spike-wave complex.

Authors:  B Weir
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1965-09

5.  Efficient unsupervised algorithms for the detection of seizures in continuous EEG recordings from rats after brain injury.

Authors:  Andrew M White; Philip A Williams; Damien J Ferraro; Suzanne Clark; Shilpa D Kadam; F Edward Dudek; Kevin J Staley
Journal:  J Neurosci Methods       Date:  2005-12-05       Impact factor: 2.390

Review 6.  Concepts of absence epilepsies: discrete syndromes or biological continuum?

Authors:  S F Berkovic; F Andermann; E Andermann; P Gloor
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

7.  EEG spike activity precedes epilepsy after kainate-induced status epilepticus.

Authors:  Andrew White; Philip A Williams; Jennifer L Hellier; Suzanne Clark; F Edward Dudek; Kevin J Staley
Journal:  Epilepsia       Date:  2009-10-20       Impact factor: 5.864

Review 8.  Genetic absence epilepsy in rats from Strasbourg--a review.

Authors:  C Marescaux; M Vergnes; A Depaulis
Journal:  J Neural Transm Suppl       Date:  1992

9.  Public statement: guidelines for the assessment and management of pain in rodents and rabbits.

Authors:  Dennis F Kohn; Thomas E Martin; Patricia L Foley; Timothy H Morris; M Michael Swindle; George A Vogler; Sally K Wixson
Journal:  J Am Assoc Lab Anim Sci       Date:  2007-03       Impact factor: 1.232

10.  gamma-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models.

Authors:  O C Snead
Journal:  Epilepsia       Date:  1988 Jul-Aug       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.